תוחם ניידות אלקטרופורטית (EMSA)
View the full transcript and gain access to JoVE Science Education videos
Q1: How does EMSA detect protein-nucleic acid binding?
EMSA detects binding by comparing migration rates of protein-nucleic acid complexes versus unbound probes through gel electrophoresis. When a protein binds to a labeled nucleic acid probe, the resulting complex has greater mass and different conformation, causing it to migrate more slowly through the gel matrix. The radioactive label makes separation easily visible, proving successful binding occurred.
Q2: Why must EMSA gels be non-denaturing?
Non-denaturing gels preserve protein conformation during electrophoresis, preventing the protein from altering shape and potentially unbinding from the probe. Polyacrylamide gels with 5-20 nm pores work for short probes up to 100 base pairs, while agarose gels with 70-700 nm pores suit larger probes. Maintaining native conditions ensures accurate detection of actual binding interactions.
Q3: What role does radioactive labeling play in EMSA?
Radioactive phosphorus-32 labeling creates a detectable probe by incubating nucleic acids with dCTP for 10 minutes. The radioactive marker allows easy visualization of separated complexes on film after electrophoresis, making it simple to identify bound versus unbound probes. This labeling approach requires radiation-safe workbenches and protective equipment during preparation.
Q4: How do binding conditions affect EMSA results?
Binding reactions use TRIS buffer at physiological pH with salt concentrations that prevent non-specific protein interactions. The reaction proceeds for 20-30 minutes at 4°C to allow proper complex formation. During electrophoresis, low ionic strength buffer and similar pH create a caging effect that stabilizes complexes, increases mobility, and reduces heat generation for optimal separation.
Q5: What is a supershift assay and why is it useful?
A supershift assay uses an antibody with known affinity to the protein to verify protein identification in EMSA. The antibody binds to the protein-nucleic acid complex, further shifting it through the gel and increasing resolution. This additional shift confirms the specific protein's presence and improves the clarity of results compared to standard EMSA alone.
Q6: How can biotinylation replace radioactive labeling in EMSA?
Biotinylation uses methyltransferase enzymes to conjugate biotin to a cofactor that binds permanently to DNA, eliminating radioactive phosphorus-32 requirements. This approach is advantageous because it is non-radioactive and site-specific in attachment, making it relevant for genotyping, methylation detection, and gene delivery applications. Biotinylated nucleic acids are detected through ultraviolet fluorescence.
Q7: What are practical applications of EMSA in studying protein-DNA interactions?
EMSA explores chromatin-remodeling enzyme binding activity by detecting mobility changes in DNA-protein complexes. It also studies response regulators activated by environmental stimuli, such as phosphorylated regulators in Desulfovibrio vulgaris that bind to specific genes affecting transcription. These applications demonstrate EMSA's versatility in analyzing diverse protein-nucleic acid binding events across biochemical processes.